Johnson & Johnson da un nuevo paso en la vacuna contra el COVID-19. La firma anunció que, a través de Janssen Pharmaceutical Companies (Janssen), aceleró el inicio de la fase 1/2a de su vacuna recombinante.…
Este sitio web utiliza cookies propias y de terceros para optimizar su navegación, adaptarse a sus preferencias y realizar labores analíticas. Al continuar navegando acepta nuestra Política de CookiesAceptar
Política de Cookies
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.